Neuro-Oncology Reviews
Volume
26 Number 7
15 April 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 7, 15 April
He W, Wang N, Wang Y, Liu M, Qing Q, Su Q, Zou Y, Liu
Y.
Engineering Nanomedicine for
Non-Viral RNA-Based Gene Therapy of Glioblastoma.
Pharmaceutics.
2024 Apr 1;16(4):482. doi:
10.3390/pharmaceutics16040482. PMID:
38675144. Review. ˍ
Sathyakumar S, Martinez M, Perreault S, Legault G, Bouffet E,
Jabado N, Larouche V, Renzi S.
Advances
in pediatric gliomas: from molecular characterization to
personalized treatments.
Eur
J Pediatr. 2024 Apr 1. doi:
10.1007/s00431-024-05540-4. PMID:
38558313. Review˰ ˍ
Savage WM, Yeary MD, Tang AJ, Sperring CP, Argenziano MG, Adapa
AR, Yoh N, Canoll P, Bruce JN.
Biomarkers
of immunotherapy in glioblastoma.
Neurooncol
Pract. 2024 Apr 1;11(4):383-394. doi:
10.1093/nop/npae028. PMID: 39006524. Review. ˍ
*Scheffler P, Fung C, Momjian S, Koessinger D, Häni L,
Neidert N, Straehle J, Volz F, Schnell O, Beck J, El Rahal
A.
Dexamethasone in Patients with
Glioblastoma: A Systematic Review and Meta-Analysis.
Cancers
(Basel). 2024 Apr 1;16(7):1393. doi:
10.3390/cancers16071393. PMID:
38611071. Review; Meta-analysis. ˍ
Mongiardi MP, Pallini R, D'Alessandris QG, Levi A, Falchetti
ML.
Regorafenib and glioblastoma: a
literature review of preclinical studies, molecular mechanisms and
clinical effectiveness.
Expert
Rev Mol Med. 2024 Apr 2;26:e5. doi:
10.1017/erm.2024.8. PMID:
38563164. Review. ˍ
*Santillán-Guaján SM, Shahi MH, Castresana
JS.
Mesenchymal-Stem-Cell-Based Therapy
against Gliomas.
Cells.
2024 Apr 2;13(7):617. doi:
10.3390/cells13070617. PMID:
38607056. Review. ˍ
Sasaki H, Kitamura Y, Toda M, Hirose Y, Yoshida
K.
Oligodendroglioma, IDH-mutant and
1p/19q-codeleted-prognostic factors, standard of care and
chemotherapy, and future perspectives with neoadjuvant
strategy.
Brain
Tumor Pathol. 2024 Apr 2. doi:
10.1007/s10014-024-00480-1. PMID:
38564040. Review˰ ˍ
Stummer W, Müther M, Spille D.
Beyond
fluorescence-guided resection: 5-ALA-based glioblastoma
therapies.
Acta
Neurochir (Wien). 2024 Apr 2;166(1):163. doi:
10.1007/s00701-024-06049-3. PMID:
38563988. Review. ˍ
Calderón-Peláez MA, Maradei Anaya SJ,
Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios
D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika
Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling
Its Potential for Oncolytic Virotherapy.
Viruses.
2024 Apr 3;16(4):561. doi:
10.3390/v16040561. PMID:
38675903;. Review. ˍ
Verma S, Malviya R, Uniyal P.
Survival
of Patients with Primary Brain Tumor: A Data Analysis of 10
Years.
Curr
Pharm Des. 2024 Apr 3. doi:
10.2174/0113816128306113240328050608. PMID:
38571355. Editorial. ˍ
Woodiwiss T, Vivanco-Suarez J, Matern T, Eschbacher KL, Greenlee
JDW.
Intraventricular Pilocytic
Astrocytoma in Adults: A 25-year Single-Center Case Series and
Systematic Review of the Literature.
World
Neurosurg. 2024 Apr 3:S1878-8750(24)00539-4. doi:
10.1016/j.wneu.2024.03.153. PMID:
38580091. Case report; Review˰
ˍ
Dimentberg E, Marceau MP, Lachance A, Bergeron-Gravel S, Saikali
S, Crevier L, Bourget C, Hawkins C, Jabado N, Giannakouros P,
Renzi S, Larouche V.
Very Long-Term
Survivorship in Pediatric DIPG: Case Report and Review of the
Literature.
J
Pediatr Hematol Oncol. 2024 Apr 4. doi:
10.1097/MPH.0000000000002853. PMID:
38573000. Case report; Review˰
ˍ
**Fine HA.
Glioblastoma: Not Just
Another Cancer.
Cancer
Discov. 2024 Apr 4;14(4):648-652. doi:
10.1158/2159-8290.CD-23-1498. PMID:
38571415. Perspective˰
ˍ
Hansford JR, Das A, McGee RB, Nakano Y, Brzezinski J, Scollon SR,
Rednam SP, Schienda J, Michaeli O, Kim SY, Greer MC, Weksberg R,
Stewart DR, Foulkes WD, Tabori U, Pajtler KW, Pfister SM, Brodeur
GM, Kamihara J.
Update on cancer
predisposition syndromes and surveillance guidelines for childhood
brain tumors.
Clin
Cancer Res. 2024 Apr 4. doi:
10.1158/1078-0432.CCR-23-4033. PMID:
38573059. Guidelines˰ ˍ
Rickel JK, Zeeb D, Knake S, Urban H, Konczalla J, Weber KJ, Zeiner
PS, Pagenstecher A, Hattingen E, Kemmling A, Fokas E, Adeberg S,
Wolff R, Sebastian M, Rusch T, Ronellenfitsch MW, Menzler K,
Habermehl L, Möller L, Czabanka M, Nimsky C, Timmermann L,
Grefkes C, Steinbach JP, Rosenow F, Kämppi L, Strzelczyk
A.
Status epilepticus in patients with
brain tumors and metastases: A multicenter cohort study of 208
patients and literature review.
Neurol
Res Pract. 2024 Apr 4;6(1):19. doi:
10.1186/s42466-024-00314-7. PMID:
38570823. Observational study; Review. ˍ
Cohen
KJ et
al, PDQ Pediatric Treatment Editorial Board.
Childhood
Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment
(PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Apr 5.
NCBI
Bookshelf
ID:
NBK65989.
PMID:
26389426.
Review. ˍ
Ghimire P, Kinnersley B, Karami G, Arumugam P, Houlston R, Ashkan
K, Modat M, Booth TC.
Radiogenomic
biomarkers for immunotherapy in glioblastoma: A systematic review
of magnetic resonance imaging studies.
Neurooncol
Adv. 2024 Apr 5;6(1):vdae055. doi:
10.1093/noajnl/vdae055. PMID:
38680991. Review. ˍ
Narsinh KH, Perez E, Haddad AF, Young JS, Savastano L,
Villanueva-Meyer JE, Winkler E, de Groot J.
Strategies
to Improve Drug Delivery Across the Blood-Brain Barrier for
Glioblastoma.
Curr
Neurol Neurosci Rep. 2024 Apr 5;24(5):123-139. doi:
10.1007/s11910-024-01338-x. PMID:
38578405.
Review. ˍ
Cella E, Bosio A, Lombardi G.
New
Insights into Glioblastoma.
Int
J Mol Sci. 2024 Apr 7;25(7):4090. doi:
10.3390/ijms25074090. PMID:
38612900. Editorial. ˍ
Majchrzak-Celińska A, Studzińska-Sroka E.
New
Avenues and Major Achievements in Phytocompounds Research for
Glioblastoma Therapy.
Molecules.
2024 Apr 8;29(7):1682. doi:
10.3390/molecules29071682. PMID:
38611962. Review. ˍ
Siegel BI, Gust J.
How Cancer Harms the
Developing Brain: Long-Term Outcomes in Pediatric Cancer
Survivors.
Pediatr
Neurol. 2024 Apr 8;156:91-98. doi:
10.1016/j.pediatrneurol.2024.03.031. PMID:
38735088. Review˰ ˍ
Chen X, Cui Y, Zou L.
Treatment
advances in high-grade gliomas.
Front
Oncol. 2024 Apr 10;14:1287725. doi:
10.3389/fonc.2024.1287725. PMID:
38660136. Review. ˍ
Dias SF, Richards O, Elliot M, Chumas P.
Pediatric-Like
Brain Tumors in Adults.
Adv
Tech Stand Neurosurg. 2024 Apr 10;50:147-183. doi:
10.1007/978-3-031-53578-9_5. PMID:
38592530. Review; Book chapter˰
ˍ
Richard SA.
The pivotal role of
irradiation-induced apoptosis in the pathogenesis and therapy of
medulloblastoma.
Cancer
Rep (Hoboken). 2024 Apr 10;7(4):e2048. doi:
10.1002/cnr2.2048. PMID:
38599791. Review. ˍ
Watanabe G, Conching A, Fry L, Putzler D, Khan MF, Haider MA,
Haider AS, Ferini G, Rodriguez-Beato FY, Sharma M, Umana GE,
Palmisciano P.
Intraventricular Glioma
in Pediatric Patients: A Systematic Review of Demographics,
Clinical Characteristics, and Outcomes.
World
Neurosurg. 2024 Apr 10:S1878-8750(24)00590-4. doi:
10.1016/j.wneu.2024.04.026. PMID:
38608813. Review˰ ˍ
Weisbrod LJ, Thiraviyam A, Vengoji R, Shonka N, Jain M, Ho W,
Batra SK, Salehi A.
Diffuse intrinsic
pontine glioma (DIPG): A review of current and emerging treatment
strategies.
Cancer
Lett. 2024 Apr 10;590:216876. doi:
10.1016/j.canlet.2024.216876. PMID:
38609002. Review˰ ˍ
Pallarés-Moratalla C, Bergers G.
The
ins and outs of microglial cells in brain health and
disease.
Front
Immunol. 2024 Apr 11;15:1305087. doi:
10.3389/fimmu.2024.1305087. PMID:
38665919. Review. ˍ
Purshouse K, Bulbeck HJ, Rooney AG, Noble KE, Carruthers RD,
Thompson G, Hamerlik P, Yap C, Kurian KM, Jefferies SJ, Lopez JS,
Jenkinson MD, Hanemann CO, Stead LF.
Adult
brain tumour research in 2024: Status, challenges and
recommendations.
Neuropathol
Appl Neurobiol. 2024 Apr 11;50(2):e12979. doi:
10.1111/nan.12979. PMID:
38605644. Guidelines. ˍ
*Won SE, Suh CH, Kim S, Park HJ, Kim KW.
Summary
of Key Points of the Response Assessment in Neuro-Oncology (RANO)
2.0.
Korean
J Radiol. 2024 Apr 11. doi:
10.3348/kjr.2024.0016. PMID:
38627876. Editorial. ˍ
Anichini G, Leiloglou M, Hu Z, O'Neill K, Daniel
Elson.
Hyperspectral and multispectral
imaging in neurosurgery: a systematic literature review and
meta-analysis.
Eur
J Surg Oncol. 2024 Apr 12:108293. doi:
10.1016/j.ejso.2024.108293. PMID:
38658267. Review˰ ˍ
*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu
Y, Qi L.
Imaging and Liquid Biopsy for
Distinguishing True Progression From Pseudoprogression in Gliomas,
Current Advances and Challenges.
Acad Radiol. 2024 Apr
12:S1076-6332(24)00162-4. doi:
10.1016/j.acra.2024.03.019. PMID:
38614827. Review. ˍ
Mikolajewicz N, Yee PP, Bhanja D, Trifoi M, Miller AM, Metellus P,
Bagley SJ, Balaj L, de Macedo Filho LJM, Zacharia BE, Aregawi D,
Glantz M, Weller M, Ahluwalia MS, Kislinger T, Mansouri
A.
Systematic Review of Cerebrospinal
Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to
Standardization and Clinical Application.
J
Clin Oncol. 2024 Apr 12:JCO2301621. doi:
10.1200/JCO.23.01621. PMID:
38608213. Review˰ ˍ
Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J,
Keniry M.
Emerging Therapies for
Glioblastoma.
Cancers
(Basel). 2024 Apr 12;16(8):1485. doi:
10.3390/cancers16081485. PMID:
38672566.
Review.
ˍ
Yang H, Li M, Deng Y, Wen H, Luo M, Zhang W.
Roles
and interactions of tumor microenvironment components in
medulloblastoma with implications for novel therapeutics.
Genes
Chromosomes Cancer. 2024 Apr 12;63(4):e23233. doi:
10.1002/gcc.23233. PMID:
38607297. Review˰ ˍ
D'Alessandris QG, Offi M, Lauretti L, Pallini R.
Personalized
Medicine in Brain Tumors.
J
Pers Med. 2024 Apr 13;14(4):413. doi:
10.3390/jpm14040413. PMID:
38673040. Editorial. ˍ
Roach JT, Riviere-Cazaux C, Wells BA, Boop FA, Daniels
DJ.
Epigenetics to clinicopathological
features: a bibliometric analysis of H3 G34-mutant diffuse
hemispheric glioma literature.
Childs
Nerv Syst. 2024 Apr 13. doi:
10.1007/s00381-024-06395-8. PMID:
38613587. Bibliometric analysis˰
ˍ
*Cohen KJ et al, PDQ Pediatric Treatment Editorial
Board.
Childhood Astrocytomas, Other
Gliomas, and Glioneuronal/Neuronal Tumors Treatment (PDQ®):
Health Professional Version.
PDQ
Cancer Inf Summ. 2024 Apr 15. NCBI
Bookshelf ID: NBK65944. PMID:
26389382. Review. ˍ
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H.
Mechanism
of Notch Signaling Pathway in Malignant Progression of
Glioblastoma and Targeted Therapy.
Biomolecules.
2024 Apr 15;14(4):480. doi:
10.3390/biom14040480. PMID:
38672496.
Review.
ˍ